ArticleClinical trials (London, England)2016

Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial.

Ethan Basch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.